Direct Contracting for High-Cost Specialty Care: What Self-Insured Employers Need to Know About Oncology, Orthopedics, and Cardiac

Primary care direct contracts are well-established at this point. Employers pay a per-member-per-month fee, employees get same-day access, and utilization of expensive downstream care drops. The model is proven.

Specialty care is a different problem entirely.

Oncology, orthopedics, and cardiac procedures represent roughly 45% of total medical spend for a typical self-insured employer, according to Health Care Cost Institute data. These three categories are also where unit cost variation is most extreme — a hip replacement billed to a commercial insurer ranges from $11,000 to $125,000 for the same procedure within a single metro market, per a 2023 RAND Corporation study on hospital price variation.

That spread is not random. It is a negotiating artifact. And direct contracting is the mechanism to close it.

---

Why Specialty Direct Contracts Are Structurally Different

In a primary care direct contract, you are essentially buying access and time. The financial model is subscription-based. Volume risk is manageable because primary care visits are frequent, predictable, and relatively low-cost per episode.

Specialty care inverts almost every one of those dynamics:

• Low frequency, high cost per episode. A cardiac bypass runs $40,000–$80,000. An employee needs one, not twelve per year.
• Significant care variation. Two orthopedic surgeons in the same building produce meaningfully different outcomes, complication rates, and total episode costs.
• Facility fees drive the bill. In oncology, chemotherapy drug costs and infusion fees can dwarf the physician fee. In orthopedics, implant costs alone represent 30–40% of total episode cost for joint replacements.
• Bundled or episode-based pricing is the norm, not the exception. You are not paying a monthly retainer. You are pricing a defined clinical event from start to finish.

---

The Three Specialty Categories: What Each Deal Looks Like

Oncology

Oncology is the hardest category to structure because care pathways are highly individual. A breast cancer case with clean margins and no metastasis is a fundamentally different financial event than a stage IV lung cancer case requiring three lines of therapy.

The most functional direct contracting approach for oncology is pathway adherence combined with fee transparency on drugs and infusion.

Here is what that means practically:

• Partner with an oncology center of excellence (COE) or a high-volume oncology group that uses evidence-based treatment pathways (Regence, Evolent, and Via Oncology all publish adherence data for participating practices).
• Negotiate drug costs separately. Oncology practices operate on a buy-and-bill model — they purchase drugs at one price, bill at another. That spread is negotiable. Ask for cost-plus pricing on chemotherapy drugs rather than AWP-based billing.
• Build quality metrics into the contract: pathway adherence rate, 30-day readmission rate, and emergency department utilization during active treatment. Tie a portion of payment to those metrics — typically 10–15% of the total contract value.

Large employers who have implemented oncology COE programs report 15–20% reductions in total oncology spend per episode, primarily through reduced unnecessary imaging, fewer off-pathway drug regimens, and lower hospitalization rates. Amazon and Boeing have both published case data on their COE programs showing this range.

Orthopedics

Orthopedics is where bundled payments have the longest track record. CMS ran the Bundled Payments for Care Improvement (BPCI) program for over a decade, generating substantial data on what works.

The standard structure:

• Define the bundle. A hip replacement bundle typically covers surgery, anesthesia, implant costs, inpatient stay, 90 days of post-acute care, and readmissions within 30 days. The total target price is set in advance.
• Negotiate implant costs separately. This is the single highest-leverage item in an orthopedic contract. Hospitals routinely bill implants at 200–400% of their actual acquisition cost. A knee implant the hospital purchased for $1,500 gets billed at $4,000–$6,000. Requiring invoice-based implant pricing is standard in any serious direct contract.
• Include the post-acute care pathway. Physical therapy and skilled nursing facility use after joint replacement drives significant cost variation. Contracts that steer toward home-based PT rather than SNF admission show 12–18% lower total episode costs, per research published in the Journal of Bone and Joint Surgery.
• Set a warranty provision. Some orthopedic direct contracts now include a complication warranty — if the patient is readmitted within 90 days for a procedure-related complication, the provider absorbs some or all of that cost. This aligns incentives directly.

Employers with 3,000+ covered lives generally produce enough orthopedic volume to negotiate meaningfully. Below that threshold, consider joining a purchasing coalition or working through a third-party administrator with existing bundled payment infrastructure.

Cardiac

Cardiac direct contracting sits between oncology and orthopedics in complexity. Elective procedures (valve replacements, bypass surgery, stent placements) are bundleable. Acute cardiac events are not — you cannot pre-price an emergency.

Focus your direct contracting efforts on the elective and semi-elective cardiac procedures:

• Coronary artery bypass graft (CABG)
• Valve repair and replacement
• Elective catheterization and stent placement
• Cardiac rhythm management (device implants)

For these procedures, the same bundle logic applies: define the episode, price it in advance, include device costs at cost-plus, and track 30-day and 90-day readmission rates as quality benchmarks.

The cardiac COE model has strong outcome data behind it. Employers who route cardiac cases to high-volume, designated cardiac centers see 20–30% lower complication rates compared to community hospital averages, according to a study published in Circulation in 2022. Volume matters in cardiac surgery. A surgeon performing 200 bypass procedures per year produces statistically better outcomes than one performing 40.

---

Contract Provisions That Matter in Specialty Deals

Regardless of specialty, these provisions belong in every direct contract:

• All-inclusive episode pricing. No surprise facility fees, assistant surgeon fees, or ancillary charges outside the defined bundle.
• Data sharing requirements. The provider must supply claims-level or encounter-level data for all covered patients. You cannot manage what you cannot see.
• Out-of-area coverage coordination. Employees traveling or living outside the primary service area need a defined care pathway. Specify it in the contract.
• Centers of excellence designation criteria. If you are calling a provider a COE, define what qualifies them: minimum annual procedure volume, board certification requirements, accreditation status, outcome benchmarks.
• Steerage incentives for employees. A direct contract with an orthopedic group does nothing if employees still walk into the nearest in-network hospital. Waive copays and deductibles for employees who use the direct contract provider. That is the standard mechanism — and it works.

---

What Employers Get Wrong

The most common mistake is treating specialty direct contracting as a procurement exercise rather than a care management strategy. Signing a bundled payment contract and walking away does not produce savings. The contract is the beginning, not the end.

Employers who see the largest savings do three things consistently:

1. They communicate directly to employees about the preferred providers and the financial benefit of using them.
2. They assign care navigation support — either in-house or through a vendor — to guide employees through specialty episodes.
3. They review contract performance data quarterly and renegotiate terms annually based on actual utilization and outcomes.

---

The Bottom Line

Primary care direct contracts reduce administrative friction and improve employee satisfaction. Specialty direct contracts reduce your largest claims. The two strategies are complementary, not interchangeable.

If your plan is spending $500,000 or more annually on oncology, orthopedics, or cardiac care — and most self-insured employers above 500 lives are — direct contracting in those categories is not an advanced strategy. It is the standard of care for employers who are serious about managing spend.

The contracts are more complex than primary care deals. The upside is proportionally larger.